Pharmacogenomics

Article	Citations
Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations	33
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing	23
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization	23
Severe systemic Adverse Reactions to Ophthalmic Timolol in a CYP2D6 Homozygous *4 Allele Carrier: A Case Report	22
Rapid point of care testing: the next frontier in pharmacogenomics	20
Pharmacogenetics of Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Patients: the SUCLINGEN Study	20
KRAS-Targeted Therapies in Advanced Solid Cancers: Drug the Undruggable?	19
Integrated in a Systems Pharmacology Approach, Pharmacogenetics holds the Promise for Personalized Medicine in Neonates	19
A Meta-Analysis of Effects of Cyp2C9 and Cyp2C19 Polymorphisms on Phenytoin Pharmacokinetic Parameters	18
Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications	17
Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations	15
Contrasting ABCB1 Pharmacogenetics and Psychotropic Responses in Child and Adolescent Psychiatry: A case comparison	15
A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level	15
Association of NAT-2 Gene Polymorphisms Toward Lung Cancer Susceptibility and Prognosis in North Indian Patients Treated with Platinum-Based Chemotherapy	14
CYP2D6 Gene Resequencing in the Malagasy, a Population at the Crossroads between Asia and Africa: A Pilot Study	12
Multiple Genetic Mutations Increase the Risk of Thrombosis Associated With Clopidogrel After Percutaneous Coronary Intervention	11
A Survey of Physician Opinions in Russia in the Field of Pharmacogenetics of Cardiovascular Disease	11
Gene Polymorphisms Affect Postoperative Imatinib Plasma Levels and Edema in Adults With Gastrointestinal Stromal Tumor	11
Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration	10
Improving the Management of ALK-Rearranged Non-Small-Cell Lung Cancer Through a Mobile Application: A Physicians-Based Survey	10
Methods for Actionable Gene Fusion Detection in Lung Cancer: Now and in the Future	10
EFfects of UGT1A , CYP2C9/19 and ABAT Polymorphisms on Plasma Concentration of Valproic Acid in Chinese Epi	10
Pharmacogenetic markers and macrolide safety in influenza patients: insights from a prospective study	10
The Promise�of Digital Health in Healthcare Equity and Medication Adherence in the Disadvantaged Dementia Population	10
The cost–effectiveness of zolbetuximab in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma	9

Cost–Effectiveness of HLA-B*58:01 Testing to Prevent Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis in Vietnam	9
UGT1A1 Genotype-Guided Dosing of Irinotecan: Time to Prioritize Patient Safety	9
Pharmacogenomics and rare diseases: optimizing drug development and personalized therapeutics	9
A critical review of RAF inhibitors in BRAF-mutated glioma treatment	8
TPMT and NUDT15 genotyping, TPMT enzyme activity and metabolite determination for thiopurines therapy: a reference laboratory experience	8
SLCO1B1 and ABCB1 Variants Synergistically Influence the Atorvastatin Treatment Response in South Indian Coronary Artery Disease Patients	8
Association between CYP3A4 , CYP3A5 and ABCB1 Genotype and Tacrolimus Treatment Outcomes Among Allogeneic H	8
Genetic Factors Associated with Tuberculosis-Related Clinical Outcomes in HIV-Infected Black African Patients: a Systematic Review and Meta-Analysis	8
Genetika+: Precision Medicine Solutions for Mental Health	8
Effects of CYP3A4 and CYP2C9 Genotype on Systemic Anastrozole and Fulvestrant Concentrations in SWOG S0226	8
Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations	8
Impact of genetic variants on fentanyl metabolism in major breast surgery patients: a candidate gene association study	8
DDX11-AS1 Modulates Dna Damage Repair to Enhance Paclitaxel Resistance of Lung Adenocarcinoma Cells	8
Head-to-head Comparison of Various Antipsychotic Agents on Genome-Wide Methylation in Schizophrenia	8
Accuracy and technical characteristics of CYP2C19 point of care tests: a systematic review	7
Polymorphisms of Genes Related to Phase II Metabolism and Resistance to Clopidogrel	7
Knowledge and Attitudes of Incoming Pharmacy Students Toward Pharmacogenomics and Survey Reliability	7
The Festival of Genetics and Personalized Medicine	7
Carbamazepine Cutaneous Adverse Reactions and HLA Gene Variation in the Chinese Population: A Systematic Review and Meta-Analysis	7
Glutathione S -transferase Gene Polymorphism and Asthma: A Case–Control Study in a Pediatric Population	7
Predicting laboratory aspirin resistance in Chinese stroke patients using machine learning models by GP1BA polymorphism	7
Donor-Derived Cell Free DNA as a Biomarker in Kidney Transplantation	7
Estimated clinical utility of multi-gene pharmacogenetic testing in a retrospective cohort of gynecology patients	7
Erratum	6
XDH Genotypes Through Gene–Gene Interactions with NUDT15 Affect Azathioprine-Induced Leukopenia in Chinese Patients	6
Polymorphisms in the CYP3A5 Gene Significantly Affect the Pharmacokinetics of Sirolimus After Kidney Transplantation	6
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case–control study	6
Exploring the Potential Benefits of Pharmacogenomics in Chronic Respiratory Diseases	6
Genetic polymorphisms of OPRM1 on the Efficacy and Safety of Anesthetic and Analgesic Agents: A Systematic Review	6
The Effects of Sex on Pharmacogenetically Guided Drug Treatment	6
Pharmacogenomics in Pediatric Medicine and Drug Development	6
Patient Satisfaction With Return of Pharmacogenomic Results Utilizing a Patient Portal Message	6
Posttransplantation diabetes mellitus (PTDM): pharmacological aspects and genetic predispositions	5
Pharmacogenomic Landscape of Covid-19 Therapies From Indian Population Genomes	5
Influence of CYP3A5 , IL-10 Polymorphisms and Metabolism Rate on Tacrolimus Exposure in Renal Post-Transplant Recipients	5
Relevance of NR1I2 Variants on Carbamazepine Therapy in Mexican Mestizos with Epilepsy at a Tertiary-Care Hospital	5
Overview of the Year 2023 at Pharmacogenomics	5
Pharmacogenomics: A Tool to Improve Medication Safety and Efficacy in Patients with Cystic Fibrosis	5
DPYD Genotyping and Predicting Fluoropyrimidine Toxicity: Where do we Stand?	5
Pharmacogenomic curriculum in Australian medical schools: a content analysis study	5
Impact of CYP2C19 Gene Polymorphisms on Warfarin Dose Requirement: A Systematic Review and Meta-Analysis	5
Dosage Optimization of Clopidogrel Via a Precision Medicine Approach: The Way Forward	5
The Genetics of Drug-Induced Qt Prolongation: Evaluating the Evidence for Pharmacodynamic Variants	5
Tabula Rasa Healthcare Company Profile: Involvement in Pharmacogenomic and Personalized Medicine Research	5
Bioinformatic Tools are Essential to Integrating Pharmacogenomics into Clinical Practice: Lessons from Neuropsychiatric Disorders	5
The Frequency Of Rs2231142 in ABCG2 Among Native Hawaiian nd Pacific Islander Subgroups: Implications for Personalized Rosuvastatin Dosing	5
Pharmacogenomic Study of Anthracycline-Induced Cardiotoxicity in Mexican Pediatric Patients	4
Clinical Pharmacology and Pharmacogenomics for Implementation of Personalized Medicine	4
Evaluation of Pentamidine Tolerability and Efficacy Between CYP2C19 Phenotypes	4
Engaging Pharmacogenomics in Pain Management and Opioid Selection	4

KCNQ1 Variant rs163184 is a Potential Biomarker of Glycemic Response to Exenatide	4
ATP Binding Cassette Transporters and Cancer: Revisiting Their Controversial Role	4
NAMPT Single-Nucleotide Polymorphism rs1319501 and Visfatin/NAMPT Affect Nitric Oxide Formation, sFlt-1 and Antihypertensive Therapy Response in Preeclampsia	4
Pharmacogenetics of Calcineurin inhibitors in kidney transplant recipients: the African gap. A narrative review	4
Relevance of NAT2 Genotype and Clinical Factors to Risk for Antituberculosis Drug-Induced Liver Injury	4
Artificial intelligence, medications, pharmacogenomics, and ethics	4
Genome-Wide Association Study of Liver Enzyme Elevation in an Extended Cohort of Rheumatoid Arthritis Patients Starting Low-Dose Methotrexate	4
Association of CYP2C19 , CYP3A4 and ABCC2 Polymorphisms and Voriconazole Plasma Concentrations in Uygur Ped	4
Single-Nucleotide Polymorphisms in ABC Drug Transporters Alter Expression and Circulating Tenofovir in Healthy South African Women Exposed to Pre-Exposure Prophylaxis	4
Pharmacogenetics of HIV Therapy: Challenges for Tailoring Treatment in Genetically Complex Populations	4
Congruence Rates for Pharmacogenomic Noninterruptive Alerts	4
Psychiatric Level 1A Evidence Pharmacogenomics in a Brazilian Admixed Cohort and Global Populations	4
SLCO1B3 Polymorphisms and Clinical Outcomes in Kidney Transplant Recipients Receiving Mycophenolate	4
Healthcare Professionals’ Knowledge, Confidence and Perceptions of Pharmacogenomics in Primary Care and Pain Management	4
Efficacy and Safety of Opioid Therapy Guided by Pharmacogenetics: A Systematic Review	4
lncRNA MALAT1 Regulates the Resistance of Breast Cancer Cells to Paclitaxel Via the miR-497-5p/ SHOC2 axis	4
Pharmacogenomic Prescribing Opportunities in Percutaneous Coronary Intervention and Bone Marrow Transplant Patients	4
The Importance of Phenoconversion when using the CYP2D6 Genotype in Clinical Practice	4
Effect of UGT1A6 and UGT2B7 polymorphisms on the valproic acid serum concentration and drug-induced liver injury	4
The Revolution of Pharmaco-Omics: Ready to Open new Avenues in Materializing Precision Medicine?	4
Leveraging Clinical Decision Support to Reduce the Risk of Discordant Pharmacogenomics Results	4
Pharmacogenomics Implementation: “ A Little Less Conversation, a Little More Action, Please ”	4
Could Pharmacogenetics Aid the Prediction of NeviRapine Pharmacokinetics and Allow Individualized Treatment?	3
Reinterpretation of pharmacogenomic phenotypes after combinatorial psychiatric testing	3
Use of a Consultation Service Following Pharmacogenetic Testing in Psychiatry	3
Validation of a Multi-Gene qPCR-Based Pharmacogenomics Panel Across Major Ethnic Groups in Singapore and Indonesia	3
Pharmacogenetic Variants Influence Vitamin K Anticoagulant Dosing in Patients with Mechanical Prosthetic Heart Valves	3
Pharmacogenetic Informed Care in Early Childhood: Options for Improving Access and Health Equity	3
Targeting RET mutation in medullary thyroid cancer	3
Analysis of the Difference in SLCO1B1 and APOE Gene Polymorphisms Between Mongolian and Han Populations	3
Pharmacogenetics Research in Brazil: A Systematic Review	3
Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada	3
Pharmacogenomic Testing to Support Prescribing in Primary Care: a Structured Review of Implementation Models	3
Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) Clinical Program at Initial Test Sites	3
Effects of the CYP2C19 LoF Allele on Major Adverse Cardiovascular Events Associated with Clopidogrel in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary	3
ABCB1 and OPRM1 Single-Nucleotide Polymorphisms Collectively Modulate Chronic Shoulder Pain and Dysfunction in South African Breast Cancer Survivors	3
Pharmacogenomic Variants Affecting Efficacy and Toxicity of Statins in a South Asian Population from Sri Lanka	3
Effects of genetic and clinical factors on thiopurine drugs pharmacokinetics in Tunisian patients	3
Implication of KDM6A in Bladder Cancer	3
Implementation of a Next-Generation Sequencing-Based Targeted Approach for Full-Length CYP3A4 Gene Sequencing	3
Whole-exome Sequencing Reveals Novel Candidate Single Nucleotide Variations for Preventing Adverse Effects of Levonorgestrel Implantation	3
Pilot Study of Multi-Gene Pharmacogenetic Testing for Pain Management in Oncology Palliative Medicine	3
The Need for a Refined Understanding of CYP2D6 in Second-Generation Antipsychotic Outcomes in Children and Adolescents	3
Integrating Pharmacogenomic Testing Into Paired Germline and Somatic Genomic Testing in Patients with Cancer	3
Influence of Polymorphisms in CYP2C9 , VKORC1 , MDR1 and APOE Genes on the W	3
Pharmacoepigenomics: A Key Determinant in Resolving Epigenomic Parameters in Pathogenesis and Treatment Response in Complex Diseases	3
Genetic Variants of the Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Reaction Element Pathway on the Risk of Antituberculosis Drug-Induced Liver Injury: A Systematic Review	3
The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress	3
Efficacy and Safety of Statins in Ethnic Differences: A Lesson for Application in Indigenous Australian Patient Care	2
Novel Associations Between Cyp2B6 Polymorphisms, Perioperative Methadone Metabolism and Clinical Outcomes in Children	2
Application of Pharmacogenomics in Supportive Oncology: A Patient Journey	2
Warfarin Pharmacogenomics in African Populations: The Importance of Ethnicity-Based Algorithms	2
Identification of Clinical and Pharmacogenetic Factors Influencing Metformin Response in Type 2 Diabetes Mellitus	2
Pharmacogenetics of 6-Mercaptopurine in a Black Zimbabwean Cohort Treated for Acute Lymphoblastic Leukaemia	2
Pharmacogenomics of Hydroxyurea Therapy and Fetal Hemoglobin Levels in Sickle Cell Anemia	2
Parental Understanding and Attitudes Following Pharmacogenomic Testing for Pediatric Neuropsychiatric Patients	2
IL16 and Factor V Gene Variations are Associated with Asparaginase-Related Thrombosis in Childhood Acute Lymphoblastic Leukemia Patients	2
Effects of MDR1 and OPRM1 Genetic Polymorphisms on the Pharmacodynamics of Propofol–Remifentanil TIVA in Pediatrics	2
Substrate Specificity of CYP2D6 Genetic Variants	2
TPMT Gene Polymorphisms (c.238G>C, c.460G>A and c.719A>G) in a Healthy Venezuelan Population	2
Impact of the PEAR 1 Polymorphism on Clinical Outcomes in Chinese Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Interventio	2
Application of Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma	2
Resolving Discordant CYP2D6 Genotyping Results in Thai Subjects: Platform Limitations and Novel Haplotypes	2
Breast Cancer Pharmacogenetics: A Systematic Review	2
The genomic landscape of CYP2D6 variation in the Indian population	2
Pharmacogenetic and Pharmacogenomic Treatment of Rheumatoid Arthritis: A Review of Pharmacogenomics Knowledge Base Scientific Evidence	2
Pharmacogenetic Differentiation Across Latin America	2
An Interview with Dr Chiara Fabbri: Pharmacogenomics and Drug Repurposing for Treatment-Resistant Depression	2
Premarket Assessment of Molecular Alterations in Drug Targets: A Case Study of 2020 Drug Approvals	2
Evaluation of pharmacogenetic automated clinical decision support for clopidogrel	2
SLCO1B3 T334G Polymorphisms and Mycophenolate Mofetil-Related Adverse Reactions in Kidney Transplant Recipients	2
The Need to Shift Pharmacogenetic Research from Candidate Gene to Genome-Wide Association Studies	2
Considering Medication Exposure in Genomic Association Studies of Cognition in Psychotic Disorders	2
Pharmacogenomics and Clinical Cultural Competency: Pathway to Overcome the Limitations of Race	2
Comparing the clinical utility of pharmacogenomic genotyping and next generation sequencing in a military health system adult medicine clinic	2
Association Between Genetic Variants and the Risk of Nivolumab-Induced Immune-Related Adverse Events	2
Pharmacogenomics in Clinical Practice to Prevent Risperidone-Induced Hyperprolactinemia in Autism Spectrum Disorder	2
Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity	2
Pharmacogenetic Loci for Rosuvastatin are Associated with Intima-Media Thickness Change and Coronary Artery Disease Risk	2
Genetic Factors in Treatment-Related Cardiovascular Complications in Survivors of Childhood Acute Lymphoblastic Leukemia	2

Effects of immunorelated gene polymorphisms on trastuzumab targeting breast cancer cell in vitro	2
Progression of Precision Statin Prescribing for Reduction of Statin-Associated Muscle Symptoms	2
Resistance to Platinum-Based Cancer Drugs: a Special Focus on Epigenetic Mechanisms	2
Antiplatelet Therapy Guided by CYP2C19 Point-of-Care Pharmacogenetics Plus Multidimensional Treatment Decisions	2
Association of Polymorphisms in ARRB2 and Clinical Response to Methadone for Pain in Advanced Cancer	2
Is there Benefit for Cyp2C19 Genotype-Guided Antiplatelet Treatment in Elderly Acute Coronary Syndrome Patients?	1
Sertraline Dosing Trends in Children and Adolescents Stratified by CYP2C19 Genotype	1
Building an Information System to Facilitate Pharmacogenomics Clinical Translation with Clinical Decision Support	1
SALL4 upregulates brain-derived neurotrophic factor to mediate Hedgehog signaling to inhibit carboplatin sensitivity in colon adenocarcinoma	1
Pharmacogenomic Markers of Metoprolol and α-OH-Metoprolol Concentrations: A Genome-Wide Association Study	1
Ethnic differences in pharmacogenomic variants: a south Asian perspective	1
AGO2 Expression Levels and Related Genetic Polymorphisms: Influence in Renal Cell Progression and Aggressive Phenotypes	1
Real-world evaluation of CYP2C19 guided antiplatelet therapy in patients undergoing intracranial aneurysm repair	1
UGT1A1 Regulatory Variant with Potential Effect on Efficacy of HIV and Cancer Drugs Commonly Prescribed in South Africa	1
The Association Between HLA-B*15:02 and Phenytoin-Induced Severe Cutaneous Adverse Reactions: A Meta-Analysis	1
Diagnosis and Treatment Monitoring in Breast Cancer: How Liquid Biopsy Can Support Patient Management	1
An Alcohol Dehydrogenase 7 Gene Polymorphism Associates with Both Acute and Chronic Pain in Sickle Cell Disease	1
Pharmacogenetics of Pain Management in Zimbabwean Patients With Sickle Cell Disease	1
PMAT Variant Rs3889348 is Associated with Metformin-Induced Gastrointestinal among Chinese Type 2 Diabetes Patients	1
Frequency and Impact of DHODH, ABCG2 and CYP2C19 SNPs on the Therapeutic Efficacy, Tolerability and Toxicity of Leflunomide	1
Challenges for the Application of Pharmacogenomics Associated with the Nomenclature of Allelic Variants	1
Inaugural Pharmacogenomics Access and Reimbursement Symposium	1
Treatment of extended RAS/ BRAF wild-type metastatic colorectal cancer with anti-EGFR antibody combinations	1
Effects of Genetic and Nongenetic Factors on Hyperuricemia in Chinese Patients with Coronary Artery Disease	1
Pharmacogenomics of Oxcarbazepine in the Treatment of Epilepsy	1
Screening and analysis of single nucleotide polymorphism in the 3′-UTR microRNA target regions and its implications for lung tumorigenesis	1
The Effect of CYP2C19 Gene Polymorphism on the Eradication Rate of Helicobacter Pylori by Proton Pump Inhibitors-ContAining Regimens in As	1
The Role of Alcohol Intake in the Pharmacogenetics of Treatment with Clozapine	1
Diversity of Pharmacogenomic Variants Affecting Warfarin Metabolism in Sri Lankans	1
Review of Pharmacogenomics of Psychiatric Comorbidities in Autism Spectrum Disorder	1
Application of the Community Dialogues Method to Identify Ethical Values and Priorities Related to Pharmacogenomics	1
rs144012689 is a Highly Specific Representative Marker of HLA-B*15:02 in the Chinese Population	1
The pharmacogenetics of treatment with olanzapine	1
Impact of Genetic Polymorphisms on Tacrolimus Trough Blood Concentration in Chinese Liver Transplant Recipients	1
Genome-Wide Association Study of Liver Enzyme Elevation in Rheumatoid Arthritis Patients Starting Methotrexate	1
Providers’ use of pharmacogenetic testing to inform opioid prescribing among veterans	1
Impact of CYP2C19 polymorphism testing on the risk of stent thrombosis in patients with carotid artery stenting	1
A Single-Tube Multiplex Real-Time PCR for HLA-B*38:02 Genotype by Detecting Highly Specific SNPs	1
Attitudes about Pharmacogenomic Testing Vary by Healthcare Specialty	1
Pharmacogenomics Education, Research and Clinical Implementation in the State of Minnesota	1
HLA-DRB1 *16:02 is Associated with PEG-Asparaginase Hypersensitivity	1
Pharmacogenomic markers associated with drug-induced QT prolongation: a systematic review	1
Pharmacogenomics Implementation Across Multiple Clinic Settings: A Qualitative Evaluation	1
HLA-B*57:01 Typing in a Malaysian Cohort: Implications of Abacavir Hypersensitivity in People Living with HIV	1
Towards Next-Generation Personalization of Tacrolimus Treatment: a Review on Advanced Diagnostic and Therapeutic Approaches	1
ARG2 Single-Nucleotide Polymorphism RS3742879 Affects Plasma Arginase 2 Levels, Nitric Oxide Formation and Antihypertensive Therapy Response in Preeclampsia	1
Clinical Pharmacogenomics Implementation In Thailand: A Dream Come True	1
Personalized Anti-Rejection Therapy with Alemtuzumab for Kidney Transplant Recipients	1
Pharmacogenetics of Clopidogrel and Warfarin in the Treatment of Cardiovascular Diseases: An Overview of Reviews	1
Effect of UGT Polymorphisms on Pharmacokinetics and Adverse Reactions of Mycophenolic Acid in Kidney Transplant Patients	1
Genetic Variants of Pear1 and Ischemic Clinical Outcomes in Coronary Artery Disease Patients: a Systematic Review and Meta-Analysis	1
CYP2C18: The Orphan in the CYP2C Family	1
HLA Pharmacogenetic Markers of Drug Hypersensitivity from the Perspective of the Populations of the Greater Middle East	1
Coriell Life Sciences: Empowering the Most Precise Medical Care for a Healthier World	1
Pharmacogenomics of Medications Given Via Nonconventional Administration Routes: A Scoping Review	1
Pharmacogenetics of Anxiety and Depression in Alzheimer’s Disease	1